Free Access
Issue
Radioprotection
Volume 49, Number 4, Octobre-Décembre 2014
Page(s) 283 - 288
DOI https://doi.org/10.1051/radiopro/2014020
Published online 30 September 2014
  • Bernardini M., Smadja C., Faraggi M., Orio S., Petitguillaume A., Desbrée A., Ghazzar N. (2014) Selective liver internal radiation therapy with 90Y resin microspheres: comparison between pre-treatment activity calculation methods, Eur. J. Med. Phys. In press. [Google Scholar]
  • CEU – Council of the European Union (2013) Council directive 2013/59/EURATOM laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom, 5 December 2013, p. 25. [Google Scholar]
  • Cremonesi M., Ferrari M., Bartolomei M., Orsi F., Bonomo G., Arico D., Mallia A., De Cicco C., Pedroli G., Paganelli G. (2008) Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment, Eur. J. Nucl. Med. Mol. Imaging 35, 2088-2096. [CrossRef] [PubMed] [Google Scholar]
  • Dale R.G. (1985) The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy, Br. J. Radiol. 58, 515-528. [CrossRef] [PubMed] [Google Scholar]
  • Dale R.G. (1989) Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model, Br. J. Radiol. 62, 241-244. [CrossRef] [PubMed] [Google Scholar]
  • Dezarn W.A., Cessna J.T., DeWerd L.A., Feng W., Gates V.L., Halama J., Kennedy A.S., Nag S., Sarfaraz M., Sehgal V., Selwyn R., Stabin M.G., Thomadsen B.R., Williams L.E., Salem R. (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies, Med. Phys. 38, 4824-4845. [CrossRef] [PubMed] [Google Scholar]
  • Gulec S.A., Mesoloras G., Stabin M. (2006) Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations, J. Nucl. Med. 47, 1209-1211. [PubMed] [Google Scholar]
  • Ho S., Lau W.Y., Leung T.W., Chan M., Ngar Y.K., Johnson P.J., Li A.K. (1996) Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours, Eur. J. Nucl. Med. 23, 947-952. [CrossRef] [PubMed] [Google Scholar]
  • O’Donoghue J.A. (1999) Implications of nonuniform tumor doses for radioimmunotherapy, J. Nucl. Med. 40, 1337-1341. [PubMed] [Google Scholar]
  • Petitguillaume A., Bernardini M., Hadid L., de Labriolle-Vaylet C., Franck D., Desbrée A. (2014a) Three-dimensional personalized Monte Carlo dosimetry in 90Y-microspheres therapy of hepatic metastases: non tumoral liver and lungs radiation protection considerations and treatment optimization, J. Nucl. Med. 55, 405-413. [CrossRef] [PubMed] [Google Scholar]
  • Petitguillaume A., Bernardini M., Broggio D., de Labriolle-Vaylet C., Franck D., Desbrée A. (2014b) OEDIPE, a software for personalized Monte Carlo dosimetry and treatment planning optimization in nuclear medicine: absorbed dose and biologically effective dose considerations, Radioprotection, 49(4)), 275-281. [Google Scholar]
  • RCR – The Royal College of Radiologists (2006) Fractionation in radiotherapy: A brief history. In: Radiotherapy dose-fractionation (Board of Faculty of Clinical Oncology, book auth.), pp. 10-13. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.